-0.87   (-1.63%)
After Hours: 52.45 -0.1400 (-0.27%)
Volume (24h) Market Cap. Day Range 52w Range
4.18M 9.29B 52.54 - 56.15 7.42 - 61.59
Jan-14-21 07:30AM Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)PR Newswire
Jan-13-21 08:02AM Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing PlatformGlobeNewswire
Jan-12-21 11:22AM News Flash: 8 Analysts Think Invitae Corporation (NYSE:NVTA) Earnings Are Under ThreatSimply Wall St.
Jan-11-21 05:35AM These 3 Big 2020 Stock Market Winners Took Big Hits MondayMotley Fool
10:26AM Looking Into Invitae's Return On Capital EmployedBenzinga
Jan-11-21 07:30AM Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable VolumePR Newswire
Jan-04-21 07:32AM The Bubble Isn’t What You Think It IsBarrons.com
Jan-01-21 02:42AM 10 Best Stocks To Buy and Hold For 5 Years According To ARK’s Cathie WoodInsider Monkey
Dec-31-20 06:34AM We Found a Bubble—but It May Not Be What You Think It IsBarrons.com
05:00AM The Best Stock Picker of 2020 Wins With Disruptive DNABloomberg
Dec-29-20 07:30AM Invitae to Present at the 39th Annual J.P. Morgan Healthcare ConferencePR Newswire
Dec-17-20 07:30AM Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses FasterPR Newswire
Dec-09-20 07:30AM Invitae to Present New Data Supporting Genetic Testing for All Breast Cancer Patients at the 2020 San Antonio Breast Cancer SymposiumPR Newswire
Nov-26-20 06:39AM TSX Venture Exchange Stock Maintenance BulletinsCNW Group
Nov-24-20 03:54AM 3 Margin-Growing UK Stocks as Lockdown Measures Ease UpGuruFocus.com
02:44AM Precision Medicine is Coming. What That Means for Patients and Investors.Barrons.com
Nov-24-20 02:19AM We're Better Off Without the Black Friday FrenzyBloomberg
Nov-19-20 10:57AM New Study Highlights the Importance of Genetic Testing for Pancreatic Cancer PatientsPR Newswire
Nov-10-20 10:35AM Imagine Holding Invitae (NYSE:NVTA) Shares While The Price Zoomed 557% HigherSimply Wall St.
Nov-09-20 07:00AM Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1GlobeNewswire
Nov-06-20 07:01AM Invitae (NVTA) Q3 2020 Earnings Call TranscriptMotley Fool
01:40AM 7 Data-Driven Stocks for a Wave of InnovationInvestorPlace
Nov-06-20 07:15AM Did You Miss NEXT's (LON:NXT) 40% Share Price Gain?Simply Wall St.
06:18AM What's Behind Invitae's Q3 Earnings BeatMotley Fool
Nov-05-20 08:00AM Invitae (NVTA) Reports Q3 Loss, Tops Revenue EstimatesZacks
04:05AM Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020PR Newswire
Nov-05-20 02:30AM Invitae Corp. to Host Earnings CallACCESSWIRE
Nov-03-20 04:02AM Pacific Biosciences of California (PACB) Q3 2020 Earnings Call TranscriptMotley Fool
Nov-02-20 08:50AM Invitae (NVTA) to Report Q3 Earnings: What's in the Cards?Zacks
06:22AM Lockdowns Mean Christmas Comes Early for AmazonBloomberg
Oct-29-20 12:34PM Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks
Oct-28-20 07:30AM Research Highlights Frequency of Genetic Risk Factors Among Men with Prostate Cancer, Suggests Role for Broader ScreeningPR Newswire
Oct-27-20 12:44PM Exact Sciences Soars on $2.15 Billion Deal for Testing FirmBloomberg
Oct-23-20 07:30AM Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020PR Newswire
Oct-22-20 08:00AM Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy DiagnosticsGlobeNewswire
Oct-08-20 07:30AM New Study Finds Germline Genetic Testing Detects Actionable Findings Missed by Tumor-only SequencingPR Newswire
Oct-07-20 10:23AM Unusual Options Activity Insight: InvitaeBenzinga
08:38AM Are Options Traders Betting on a Big Move in Invitae (NVTA) Stock?Zacks
Oct-05-20 07:30AM Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients WorldwidePR Newswire
Oct-01-20 02:22AM 7 Diagnostic and Genomic Stocks Storming Into OctoberZacks
06:59AM What Is NEXT plc's (LON:NXT) Share Price Doing?Simply Wall St.
Sep-30-20 06:04AM Better Buy: Invitae vs. IlluminaMotley Fool
Sep-22-20 07:02AM Will Covid-19 Steal Christmas in the U.K. This Year?Bloomberg
Sep-17-20 08:24AM European stocks fall, Dow futures slump 300 points as traders react to Fed decisionMarketWatch
05:33AM European stocks fall, Dow futures slump 250 points as traders react to Fed decisionMarketWatch
Sep-17-20 03:33AM European stocks fall, Dow futures slump 300 points as traders react to Fed decisionMarketWatch
Sep-16-20 01:39AM StockBeat: Inditex, H&M Put Fashion Back in FashionInvesting.com
Sep-15-20 05:00AM Betting on a V-Shaped Recovery, and WinningBloomberg
Sep-14-20 04:50AM L Brands Announces Partnership with Next PLC for Victoria’s Secret UKGlobeNewswire
Sep-11-20 07:30AM Invitae Appoints Kimber Lockhart to its Board of DirectorsPR Newswire
Invitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; proactive health and wellness screening; and preimplantation embryo testing and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It also operates Patient Insights Networks, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform that is used for the collection, analysis, and management of patient family history information. Invitae Corporation serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.
Cap:    |  Volume (24h):